Novartis said Wednesday it received approval in Japan to market four drugs to treat asthma, cancer, hypertension and blindness.
More: continued here
Novartis said Wednesday it received approval in Japan to market four drugs to treat asthma, cancer, hypertension and blindness.
More: continued here